HomeMission | Investigators | Transgenic Mouse Facility | PCR Core Facility | Human Tumor BankCareer Opps
Funding Opportunities | Cancer Cell Biology Track | SCCCB Pre-doctoral Fellowship | Seminars | News | Related Links | Site Index


 

Xiaodong Cheng, Ph.D.
Associate Professor
Department of Pharmacology and Toxicology
email:  xcheng@utmb.edu


The study of signal transduction provides fundamental information regarding the regulation of biological processes that support the function of life under normal and disease states. Our laboratory is interested in elucidating the functional roles of exchange protein directly activated by cAMP (Epac) and cAMP-dependent protein kinase (PKA) in the overall cAMP-mediated intracellular signaling by determining the down-stream effectors of Epac and different PKA isoforms, as well as their mechanisms of activation. In addition, we are investigating the complex intracellular signaling pathways important for oncogenic transformation using genetically-defined human cancer models and functional proteomics approaches.

 

Yu, S., Fan, F., Mei, F., and Cheng, X. Investigating the mechanism of exchange protein directly activated by cAMP activation by FT-IR and structural modeling. Biochemistry. 45:15318-15326, 2006.

Mei, F. Young, T. W., and Cheng, X. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J., 20:497-499, 2006.

Ji, Z., Mei, F. C., Johnson, B. H., Thompson, E. B., and Cheng, X. PKA, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J. Biol. Chem.282:37370-37377, 2007.

Brock, M., Fan, F., Mei, F., Li, S., Gessner, C., Woods Jr., V. L., and Cheng, X. Conformational analysis of Epac activation revealed using amide hydrogen/deuterium exchange mass spectrometry (DXMS). J. Biol. Chem. 282:32256-32263, 2007.

Cheng, X., Young, T. W., and Mei, F. C. Proteomics analyses of ovarian cancer using genetically defined human ovarian cancer models. Frontiers in Bioscience. 12:5166-5176, 2007.

Young, T. W., Rosen, D. G., Mei, F., Li, N., Liu, J., and Cheng, X. Up-regulation of Tumor Susceptibility Gene 101 Conveys poor Prognosis through Suppression of p21 Expression in Ovarian Cancer. Clinical Cancer Research. 13:3848-3854, 2007.

Ji, Z., Mei, F. C., Xie. J. and Cheng, X. Oncogenic KRAS supresses GLI1 degradation and activates hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem. 282:14048-14055, 2007.

Young, T.W., Mei, F.C., Rosen, D.G., Yang, G., Li, N., Liu, J., and Cheng, X. Up-regulation of tumor susceptibility gene 101 protein in human epithelial ovarian cancer revealed by functional proteomics. Molecular and Cellular Proteomics. 6:294-304, 2007.

Li, J., O’Conner, K. L., Cheng, X., Mei, F. C., Uchida, T., Townsend, C. M., and Evers, B. M. Cyclic AMP-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and PKA signaling pathways. Molecular Endocrinology. 21:159-171, 2007.

Wayne, C. W., Fan, H. Y., Cheng, X., and Richards, J. S. FSH induces multiple signaling cascades: evidence that activation RAS, SRC and the EGF receptor are critical for granulosa cell differentiation. Molecular Endocrinology. 21:1940-1957, 2007.



HomeMission | Investigators | Transgenic Mouse Facility | PCR Core Facility | Human Tumor BankCareer Opps
Funding Opportunities | Cancer Cell Biology Track | SCCCB Pre-doctoral Fellowship | Seminars | News | Related Links | Site Index

This site published by Donna Davis for the Sealy Center for Cancer Cell Biology.
Copyright ©  2002, 2003  The University of Texas Medical Branch. Please review our privacy policy and Internet guidelines.

Site Last Revised: January 15, 2008